Labcorp
Labcorp, officially known as Laboratory Corporation of America Holdings, is a leading global life sciences company headquartered in the United States. Founded in 1971, Labcorp has established itself as a key player in the diagnostics and drug development sectors, with a strong presence across North America and Europe. The company offers a comprehensive range of laboratory services, including clinical laboratory testing, drug development, and genomic testing. Labcorp's commitment to innovation and quality sets it apart, providing healthcare professionals with critical insights to improve patient outcomes. Recognised for its extensive test menu and advanced technologies, Labcorp has achieved significant milestones, including the introduction of pioneering diagnostic solutions. With a robust market position, Labcorp continues to drive advancements in healthcare, making it a trusted partner for patients and providers alike.
DitchCarbon Score
How does Labcorp's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Labcorp's score of 56 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Labcorp's reported carbon emissions
In 2024, Labcorp reported total greenhouse gas emissions of approximately 313,802,000 kg CO2e for Scope 1 and 2 combined, with Scope 1 emissions at about 187,455,000 kg CO2e and Scope 2 emissions at approximately 126,346,000 kg CO2e (market-based). The company also disclosed significant Scope 3 emissions, totalling about 543,229,000 kg CO2e from purchased goods and services, and additional emissions from upstream and downstream transportation and distribution. Labcorp has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2020 as the baseline year. This target is aligned with the Science Based Targets initiative (SBTi) and reflects a commitment to reducing Scope 3 emissions by 25% within the same timeframe. The company has also pledged to achieve net zero emissions by 2030 for both Scope 1 and Scope 2 emissions. Over the past few years, Labcorp's emissions have shown fluctuations, with Scope 1 emissions decreasing from approximately 182,265,000 kg CO2e in 2023 to about 187,455,000 kg CO2e in 2024. Scope 2 emissions also varied, with a market-based total of about 149,702,000 kg CO2e in 2023 compared to approximately 126,346,000 kg CO2e in 2024. Labcorp's climate strategy is part of a broader commitment to sustainability within the pharmaceuticals and biotechnology sector, reflecting an increasing focus on reducing carbon footprints and enhancing environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 69,115,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 178,899,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Labcorp is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
